Kanyin Liane Ong, Lauryn K Stafford, Susan A. McLaughlin, Edward J. Boyko, Stein Emil Vollset, Amanda Elizabeth Smith, Bronte E Dalton, Joe Duprey, Jessica A Cruz, Hailey Hagins, Paulina A Lindstedt, Amirali Aali, Yohannes Habtegiorgis Abate, Melsew Dagne Abate, Mohammadreza Abbasian, Zeinab Abbasi-Kangevari, Mohsen Abbasi‐Kangevari, Samar Abd ElHafeez, Rami Abd‐Rabu, Deldar Morad Abdulah, Abu Yousuf Md Abdullah, Vida Abedi, Hassan Abidi, Richard Gyan Aboagye, Hassan Abolhassani, Eman Abu‐Gharbieh, Ahmed Abu‐Zaid, Tigist Demssew Adane, Denberu Eshetie Adane, Isaac Yeboah Addo, Oyelola Abdulwasiu Adegboye, Victor Adekanmbi, Victor Abiola Adepoju, Qorinah Estiningtyas Sakilah Adnani, Rotimi Felix Afolabi, Gina Agarwal, Zahra Babaei Aghdam, Marcela Agudelo‐Botero, Constanza Elizabeth Aguilera Arriagada, Williams Agyemang‐Duah, Bright Opoku Ahinkorah, Danish Ahmad, Rizwan Ahmad, Sajjad Ahmad, Aqeel Ahmad, Ali Ahmadi, Keivan Ahmadi, Ayman Ahmed, Ali Ahmed, Luai Awad Ahmed, Syed Anees Ahmed, Marjan Ajami, Rufus Akinyemi, Hanadi Khamis Al Hamad, Syed Mahfuz Al Hasan, Tareq Mohammed Ali AL-Ahdal, Tariq A. Alalwan, Ziyad Al‐Aly, Mohammad T AlBataineh, Jacqueline Elizabeth Alcalde Rabanal, Sharifullah Alemi, Hassam Ali, Tahereh Alinia, Syed Mohamed Aljunid, Sami Almustanyir, Rajaa Mohammad Al-Raddadi, Nelson Alvis‐Guzmán, Firehiwot Amare, Edward Kwabena Ameyaw, Sohrab Amiri, Ganiyu Adeniyi Amusa, Cătălina Liliana Andrei, Ranjit Mohan Anjana, Adnan Ansar, Golnoosh Ansari, Alireza Ansari‐Moghaddam, Anayochukwu Edward Anyasodor, Jalal Arabloo, Aleksandr Y. Aravkin, Demelash Areda, Hidayat Arifin, Mesay Arkew, Benedetta Armocida, Johan Ärnlöv, Anton A Artamonov, Judie Arulappan, Raphael Taiwo Aruleba, Ashokan Arumugam, Zahra Aryan, Mulu Tiruneh, Mohammad Asghari Jafarabadi, Elaheh Askari, Daniel Asmelash, Thomas Astell‐Burt, Mohammad Athar, Seyyed Shamsadin Athari, Maha Moh’d Wahbi Atout, Leticia Ávila‐Burgos, Ahmed Awaisu, Sina Azadnajafabad, Darshan Bhagawan, Hassan Babamohamadi, Muhammad Badar, Alaa Badawi, Ashish Badiye, Nayereh Baghcheghi, Nasser Bagheri, Sara Bagherieh, Sulaiman M. Bah, Saeed Bahadory, Ruhai Bai, Atif Amin Baig, Ovidiu Constantin Baltatu, Hamid Reza Baradaran, Martina Barchitta, Mainak Bardhan, Noël Christopher Barengo, Till Bärnighausen, Mark Thomaz Ugliara Barone, Francesco Barone‐Adesi, Amadou Barrow, Hamideh Bashiri, Afisu Basiru, Sanjay Basu, Saurav Basu, Abdul-Monim Mohammad Batiha, Kavita Batra, Mulat Tirfie Bayih, Nebiyou Simegnew Bayileyegn, Amir Hossein Behnoush, Alehegn Bekele Bekele, Melaku Ashagrie Belete, Uzma Iqbal Belgaumi, Luı́s Belo, Derrick Bennett, Isabela M. Benseñor, Kidanemaryam Berhe, Alemshet Yirga Berhie, Sonu M. M. Bhaskar, Ajay Nagesh Bhat, Jasvinder Singh Bhatti, Boris T. Bikbov, Faiq Bilal, Bagas Suryo Bintoro, Saeid Bitaraf, Veera Raghavulu Bitra, Vesna M. Bjegovic-Mikanovic, Virginia Bodolica, Archith Boloor, Michael D Brauer, Javier Brazo‐Sayavera, Hermann Brenner, Zahid A Butt, Daniela Cornelia Călina, Luciana Aparecida Campos, Ismael Campos‐Nonato, Yin Cao, Chao Cao, Josip Car, Márcia C. Carvalho, Carlos Andrés Castañeda-Orjuela, Ferrán Catalá-López, Ester Cerin, Joshua Chadwick, Eeshwar K Chandrasekar, Gashaw Sisay Chanie, Jaykaran Charan, Vijay Kumar Chattu, Kirti Chauhan, Huzaifa Ahmad Cheema, Endeshaw Chekol Abebe, Simiao Chen, Nicolas Cherbuin, Fatemeh Chichagi, Saravana Babu Chidambaram, William Chi Shing Cho, Sonali Gajanan Choudhari, Rajiv Chowdhury, E. Chowdhury, Dinh‐Toi Chu, Isaac Sunday Chukwu, Sheng‐Chia Chung, Kaleb Coberly, Alyssa Columbus, Daniela Contreras, Ewerton Cousin, Michael H Criqui, Natália Alves Martins, Sarah Cuschieri, Bashir Dabo, Omid Dadras, Xiaochen Dai, Albertino Antonio Moura Damasceno, Rakhi Dandona, Lalit Dandona, Saswati Das, Ana Maria Dascălu, Nihar Ranjan Dash, Mohsen Dashti, Claudio Alberto Dávila-Cervantes, Vanessa Vianey De la Cruz-Góngora, Gebiso Roba Debele, Kourosh Delpasand, Fitsum Wolde Demisse, Getu Debalkie Demissie, Xin Deng, Edgar Denova‐Gutiérrez, Salil Vasudeo Deo, Emina Dervišević, Hardik Dineshbhai Desai, Aragaw Tesfaw Desale, Anteneh Mengist Dessie, Fikreab Desta, Syed Masudur Rahman Dewan, Sourav Dey, Kuldeep Dhama, Meghnath Dhimal, Nancy Diao, Daniel Díaz, Monica Gabriela Dinu, Mengistie Diress, Shirin Djalalinia, Linh Phuong Doan, Deepa Dongarwar, Francisco Winter dos Santos Figueiredo, Bruce Bartholow Duncan, Siddhartha Dutta, Arkadiusz Marian Dziedzic, Hisham Atan Edinur, Michael Ekholuenetale, Temitope Cyrus Ekundayo, Islam Y. Elgendy, Muhammed Elhadi, Waseem El‐Huneidi, Omar El Meligy, Mohamed A. Elmonem, Destaw Endeshaw, Hawi Leul Esayas, Habitu Birhan Eshetu, Farshid Etaee, Ibtihal Fadhil, Adeniyi Francis Fagbamigbe, Ayesha Fahim, Shahab Falahi, MoezAlIslam E. Faris, Hossein Farrokhpour, Farshad Farzadfar, Ali Fatehizadeh, Ghazal S. Fazli, Xiaoqi Feng, Tomas Y Ferede, Florian Fischer, David C. Flood, Ali Forouhari, Roham Foroumadi, Masoumeh Foroutan Koudehi, Abhay Motiramji Gaidhane, Santosh Gaihre, Abduzhappar Gaipov, Yaseen Galali, Balasankar Ganesan, MA Garcia-Gordillo, Rupesh Kumar Gautam, Mesfin Gebrehiwot, Kahsu Gebrekirstos Gebrekidan, Teferi Gebru Gebremeskel, Lemma Getacher, Fataneh Ghadirian, Seyyed‐Hadi Ghamari, Mohammad Ghasemi Nour, Fariba Ghassemi, Mahaveer Golechha, Pouya Goleij, Davide Golinelli, Sameer Vali Gopalani, Habtamu Alganeh Guadie, Shi‐Yang Guan, Temesgen Worku Gudayu, Rafael Alves Guimarães, Rashid Abdi Guled, Rajeev Gupta, Kartik Gupta, Veer Bala Gupta, Vivek Gupta, Bishal Gyawali, Rasool Haddadi, Najah R Hadi, Teklehaimanot Gereziher Haile, Ramtin Hajibeygi, Arvin Haj‐Mirzaian, Rabih Halwani, Samer Hamidi, Graeme J. Hankey, Md. Abdul Hannan, Shafiul Haque, Hamid Harandi, Netanja I. Harlianto, S M Mahmudul Hasan, Syed Shahzad Hasan, Hamidreza Hasani, Soheil Hassanipour, Mohammed Bheser Hassen, Johannes Haubold, Khezar Hayat, Golnaz Heidari, Mohammad Heidari, Kamran Hessami, Yuta Hiraike, Ramesh Holla, Sahadat Hossain, Md Shakhaoat Hossain, Mohammad‐Salar Hosseini, Mehdi Hosseinzadeh, Hassan Hosseinzadeh, Junjie Huang, Md. Nazmul Huda, Salman Hussain, Hong-Han Huynh, Bing‐Fang Hwang, Segun Emmanuel Ibitoye, Nayu Ikeda, Irena Ilić, Milena Ilić, Leeberk Raja Inbaraj, Afrin Iqbal, Sheikh Mohammed Shariful Islam, Rakibul M. Islam, Nahlah Elkudssiah Ismail, Hiroyasu Iso, Gaetano Isola, Ramaiah Itumalla, Masao Iwagami, Chidozie C D Iwu, Ihoghosa Osamuyi Iyamu, Assefa N Iyasu, Louis Jacob, Abdollah Jafarzadeh, Haitham Jahrami, Rajesh Kumar Jain, Chinwe Jaja, Zahra Jamalpoor, Elham Jamshidi, Balamurugan Janakiraman, Krishnamurthy Jayanna, Sathish Kumar Jayapal, Shubha Jayaram, Ranil Jayawardena, Rime Jebai, Wonjeong Jeong, Yinzi Jin, Mohammad Jokar, Jost Bruno Jonas, Nitin Joseph, Abel A. Joseph, Charity Ehimwenma Joshua, Farahnaz Joukar, Jacek Jerzy Jozwiak, Billingsley Kaambwa, Ali Kabir, Robel Hussen Kabthymer, Vidya Kadashetti, Farima Kahe, Rohollah Kalhor, Himal Kandel, Shama D. Karanth, Ibraheem M. Karaye, Samad Karkhah, Patrick DMC Katoto, Navjot Kaur, Sina Kazemian, Sewnet Adem Kebede, Yousef Saleh Khader, Himanshu Khajuria, Amirmohammad Khalaji, Moien AB Khan, Maseer Khan, Ajmal Khan, Saval Khanal, Moawiah Mohammad Khatatbeh, Amir M Khater, Sorour Khateri, Fatemeh Khorashadizadeh, Jagdish Khubchandani, Biruk Getahun Kibret, Min Seo Kim, Ruth W Kimokoti, Adnan Kısa, Mika Kivimäki, Ali‐Asghar Kolahi, Somayeh Komaki, Farzad Kompani, Hamid Reza Koohestani, Oleksii Korzh, Karel Kostev, Nikhil Kothari, Ai Koyanagi, Kewal Krishan, Yuvaraj Krishnamoorthy, Barthélémy Kuate Defo, Mohammed Kuddus, Md Abdul Kuddus, Rakesh Kumar, Harish Kumar, Satyajit Kundu, Maria Dyah Kurniasari, Ambily Kuttikkattu, Carlo La Vecchia, Tea M. Lallukka, Bagher A. Larijani, Anders O. Larsson, Kamaluddin Latief, Basira Kankia Lawal, Thao T. Le, Trang Thi Bich Le, Shaun Wen Huey Lee, Munjae Lee, Wei‐Chen Lee, Paul Hong Lee, Sang-woong Lee, Seung Won Lee, Samson Mideksa Legesse, Jacopo Lenzi, Yongze Li, Ming‐Chieh Li, Stephen S Lim, Lee‐Ling Lim, Xuefeng Liu, Chaojie Liu, Chun‐Han Lo, Graciliana Lopes, Stefan Lorkowski, Rafael Lozano, Giancarlo Lucchetti, Azzam A. Maghazachi, Phetole Walter Mahasha, S. Mahjoub, Mansour Adam Mahmoud, Razzagh Mahmoudi, Marzieh Mahmoudimanesh, Anh Tuan Mai, Azeem Majeed, Pantea Majma Sanaye, Konstantinos C. Makris, Kashish Malhotra, Ahmad Azam Malik, Iram Malik, Tauqeer Hussain Mallhi, Déborah Carvalho Malta, Abdullah Al Mamun, Borhan Mansouri, Hamid Reza Marateb, Parham Mardi, Santi Martini, Miquel Martorell, Roy Rillera Marzo, Reza Masoudi, Sahar Masoudi, Elezebeth Mathews, Andrea Maugeri, Giampiero Mazzaglia, Teferi Mekonnen, Mahboobeh Meshkat, Tomislav Meštrović, Junmei Miao Jonasson, Tomasz Miazgowski, Irmina Maria Michałek, Le Huu Nhat Minh, GK Mini, J. Jaime Miranda, Reza Mirfakhraie, Erkin Mirsaidovich Mirrakhimov, Mohammad Mirza‐Aghazadeh‐Attari, Awoke Misganaw, Kebede Haile Misgina, Manish Mishra, Babak Moazen, Nouh Saad Mohamed, Esmaeil Mohammadi, Mohsen Mohammadi, Abdollah Mohammadian-Hafshejani, Marita Mohammadshahi, Alireza Mohseni, Hoda Mojiri-Forushani, Ali H. Mokdad, Sara Momtazmanesh, Lorenzo Monasta, Md. Moniruzzaman, Ute Mons, Fateme Montazeri, AmirAli Moodi Ghalibaf, Yousef Moradi, Maryam Moradi, Mostafa Moradi Sarabi, Negar Morovatdar, Shane Douglas Morrison, Jakub Morze, Elias A. Mossialos, Ebrahim Mostafavi, Ulrich Otto Mueller, Francesk Mulita, Admir Mulita, Efrén Murillo‐Zamora, Kamarul Imran Musa, Julius Chacha Mwita, Shankar Prasad Nagaraju, Mohsen Naghavi, Firzan Nainu, Tapas Sadasivan Nair, Hastyar Hama Rashid Najmuldeen, Vinay B. Nangia, Shumaila Nargus, Abdallah Y. Naser, Hasan Nassereldine, Zuhair Saleh Natto, Javaid Nauman, Biswa Prakash Nayak, Rawlance Ndejjo, Hadush Tesfay Negash, Ruxandra Irina Negoi, Hau Thi Hien Nguyen, Dang H. Nguyen, Phat Tuan Nguyen, Văn Thành Nguyễn, Hien Quang Nguyen, Robina Khan Niazi, Yeshambel T. Nigatu, Dina Nur Anggraini Ningrum, Muhammad A Nizam, Lawrence Achilles Nnyanzi, Mamoona Noreen, Jean Jacques Noubiap, Ogochukwu Janet Nzoputam, Chimezie Igwegbe Nzoputam, Bogdan Oancea, Nkechi Martina Odogwu, Oluwakemi Ololade Odukoya, Vivek Anand Ojha, Hassan Okati‐Aliabad, Akinkunmi Paul Okekunle, Osaretin Christabel Okonji, Patrick Godwin Okwute, Isaac Iyinoluwa Olufadewa, Obinna Emmanuel Onwujekwe, Michał Ordak, Alberto Ortíz, Uchechukwu Levi Osuagwu, Abderrahim Oulhaj, Mayowa Ojo Owolabi, Alicia Padrón‐Monedero, Jagadish Rao Padubidri, Raffaele Palladino, Demosthenes B. Panagiotakos, Songhomitra Panda‐Jonas, Ashok Pandey, Anamika Pandey, Seithikurippu Ratnas Pandi-Perumal, Anca Pantea Stoian, Shahina Pardhan, Tarang Parekh, Utsav Parekh, Maja Pasovic, Jay Patel, Jenil R Patel, Uttam Paudel, Veincent Christian Filipino Pepito, Marcos Emanoel Pereira, Norberto Perico, Simone Perna, Ionela-Roxana Petcu, Fanny Emily Petermann-Rocha, Vivek Podder, Maarten Jacobus Postma, Ghazaleh Pourali, Naeimeh Pourtaheri, Elton Junio Sady Prates, Mirza Muhammad Fahd Qadir, Ibrahim Qattea, Pourya Raee, Ibrar Rafique, Mehran Rahimi, Mahban Rahimifard, Vafa Rahimi‐Movaghar, Obaidur Rahman, Muhammad Aziz Rahman, Mohammad Hifz Ur Rahman, Mosiur Rahman, Md. Mosfequr Rahman, Mohamed Rahmani, Shayan Rahmani, Vahid Rahmanian, Setyaningrum Rahmawaty, Niloufar Rahnavard, Bibek Rajbhandari, Pradhum Ram, Sheena Ramazanu, Juwel Rana, Nemanja Rančić, Muhammad Modassar Ali Nawaz Ranjha, Chythra Raghavendra Rao, Deepthi Rapaka, Drona Prakash Rasali, Sina Rashedi, Vahid Rashedi, Ahmed Mustafa Rashid, Mohammad‐Mahdi Rashidi, Zubair Ahmed Ratan, Salman Rawaf, Lal Bahadur Rawal, Elrashdy M Moustafa Mohamed Redwan, Giuseppe Remuzzi, Kannan R. R. Rengasamy, André M. N. Renzaho, Luis Felipe Reyes, Nima Rezaei, Nazila Rezaei, Mohsen Rezaeian, Hossein Rezazadeh, Seyed Mohammad Riahi, Yohanes Andy Rias, Muhammad Riaz, Daniela Ribeiro, Mónica Rodrigues, Jefferson Antonio Buendía, Leonardo Roever, Peter J Rohloff, Gholamreza Roshandel, Abazar Roustazadeh, Godfrey Mutashambara Rwegerera, Aly M A Saad, Maha Mohamed Saber-Ayad, Siamak Sabour, Leila Sabzmakan, Basema Ahmad Saddik, Erfan Sadeghi, Umar Abid Saeed, Sahar Saeedi Moghaddam, Sare Safi, Sher Zaman Safi, Amene Saghazadeh, Narjes Saheb Sharif‐Askari, Fatemeh Saheb Sharif‐Askari, Amirhossein Sahebkar, Soumya Swaroop Sahoo, Harihar Sahoo, KM Saif‐Ur‐Rahman, Mirza Rizwan Sajid, Sarvenaz Salahi, Saina Salahi, Mohamed Ahmed Saleh, Mohammad Amin Salehi, Joshua A. Salomon, Juan Ramon Sanabria, Rama Krishna Sanjeev, Francesco Sanmarchi, Milena M Santric-Milicevic, Made Ary Sarasmita, Saman Sargazi, Brijesh Sathian, Thirunavukkarasu Sathish, Monika S. Sawhney, Markus Peter Schlaich, María Inês Schmidt, Art Schuermans, Abdul-Aziz Seidu, Nachimuthu Senthil Kumar, Sadaf Ghajarieh Sepanlou, Yashendra Sethi, Allen Seylani, Maryam Shabani, Tahereh Shafaghat, Melika Shafeghat, Mahan Shafie, Nilay S. Shah, Samiah Shahid, Masood Ali Shaikh, Mohd Shanawaz, Mohammed Shannawaz, Sadaf Sharfaei, Bereket Beyene Shashamo, Rahman Shiri, Aminu Shittu, K. M. Shivakumar, Siddharudha Shivalli, Parnian Shobeiri, Fereshteh Shokri, Kerem Shuval, Migbar Mekonnen Sibhat, Luís R. Silva, Colin R Simpson, Ambrish Singh, Paramdeep Singh, Surjit Singh, Md Shahjahan Siraj, Anna Aleksandrovna Skryabina, Abdullah Al Mamun Sohag, Hamidreza Soleimani, Solikhah Solikhah, Mohammad Sadegh Soltani‐Zangbar, Ranjani Somayaji, Reed J D Sorensen, Antonina Vladimirovna Starodubova, Sujata Sujata, Muhammad Suleman, Jing Sun, Johan Sundström, Rafael Tabarés‐Seisdedos, Seyyed Mohammad Tabatabaei, Seyed‐Amir Tabatabaeizadeh, Mohammad Tabish, Majid Taheri, Ensiyeh Taheri, Elahe Taki, Jacques Lukenze Tamuzi, Ker‐Kan Tan, Nathan Y Tat, Birhan Tsegaw Taye, Worku Animaw Temesgen, Mohamad-Hani A. Temsah, Riki Tesler, Pugazhenthan Thangaraju, Kavumpurathu Raman Thankappan, Rajshree Thapa, Samar Tharwat, Nihal Thomas, Jansje Henny Vera Ticoalu, Amir Tiyuri, Marcello A. Tonelli, Marcos Roberto Tovani‐Palone, Domenico Tricò, Indang Trihandini, Jaya Prasad Tripathy, Samuel Joseph Tromans, Guesh Mebrahtom, Abdul Rohim Tualeka, Derara Girma, Stefanos Tyrovolas, Sana Ullah, Era Upadhyay, Seyed Mohammad Vahabi, Asokan Govindaraj Vaithinathan, Rohollah Valizadeh, Kim Robin van Daalen, Priya Vart, Shoban Babu Varthya, Tommi Juhani Vasankari, Siavash Vaziri, Madhur Verma, Georgios‐Ioannis Verras, Danh Cao Vo, Birhanu Wagaye, Yasir Waheed, Ziyue Wang, Yanqing Wang, Cong Wang, Fang Wang, Gizachew Tadesse Wassie, Melissa Y. Wei, Abrha Hailay, Ronny Westerman, Nuwan Darshana Wickramasinghe, Yifan Wu, Ratna Dwi Wulandari, Juan Xia, Hong Xiao, Suowen Xu, Xiaoyue Xu, Dereje Y Yada, Lin Yang, Hiroshi Yatsuya, Metin Yeşiltepe, Siyan Yi, Hunachew Kibret Yohannis, Naohiro Yonemoto, Yuyi You, Sojib Bin Zaman, Nelson Zamora, Iman Zare, Kourosh Zarea, Armin Zarrintan, Михаил Сергеевич Застрожин, Naod Gebrekrstos Zeru, Zhi-Jiang Zhang, Chenwen Zhong, Jingjing Zhou, Magdalena Zielińska, Yossef Teshome Zikarg, SANJAY P. ZODPEY, Mohammad Zoladl, Zhiyong Zou, Alimuddin I. Zumla, Yves Miel H Zuñiga, Dianna J. Magliano, Christopher J L Murray, Simon Iain Hay, Theo Vos
7 min
This study provides a comprehensive analysis of the global, regional, and national burden of diabetes from 1990 to 2021, utilizing the Global Burden of Disease (GBD) framework. The researchers estimated the prevalence of type 1 and type 2 diabetes across 204 countries and territories, quantified the contribution of 16 specific risk factors to the type 2 diabetes burden, and projected future prevalence rates through 2050.
To generate these estimates, the authors integrated data from vital registration, verbal autopsies, scientific literature, survey microdata, and insurance claims. They employed the Cause of Death Ensemble model (CODEm) for mortality estimates and the DisMod-MR 2.1 Bayesian meta-regression tool for prevalence. The study specifically separated type 1 and type 2 diabetes, with type 2 estimates derived by subtracting type 1 cases from total diabetes prevalence. Risk-attributable burden was calculated using a comparative risk assessment framework, focusing on factors like high BMI, dietary risks, and physical inactivity.
The global age-standardised prevalence of diabetes reached 6.1% in 2021, with significant regional disparities; North Africa and the Middle East reported the highest rates. Type 2 diabetes remains the dominant form of the disease, responsible for the vast majority of cases and disability-adjusted life-years (DALYs). High BMI was identified as the leading risk factor, contributing to over 52% of type 2 diabetes DALYs globally. Looking ahead, the study projects a massive increase in the global diabetes population, reaching 1.31 billion by 2050, driven by both demographic shifts and rising obesity rates.
Diabetes represents a monumental public health challenge that is currently outpacing global prevention efforts. The findings underscore that without significant, multifaceted interventions—particularly those addressing the obesity epidemic and social determinants of health—the burden on global healthcare systems will continue to escalate. The granular data provided serves as a critical resource for policymakers to identify high-risk populations and allocate resources for early diagnosis and management.
BACKGROUND: Diabetes is one of the leading causes of death and disability worldwide, and affects people regardless of country, age group, or sex. Using the most recent evidentiary and analytical framework from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), we produced location-specific, age-specific, and sex-specific estimates of diabetes prevalence and burden from 1990 to 2021, the proportion of type 1 and type 2 diabetes in 2021, the proportion of the type 2 diabetes burden attributable to selected risk factors, and projections of diabetes prevalence through 2050. METHODS: Estimates of diabetes prevalence and burden were computed in 204 countries and territories, across 25 age groups, for males and females separately and combined; these estimates comprised lost years of healthy life, measured in disability-adjusted life-years (DALYs; defined as the sum of years of life lost [YLLs] and years lived with disability [YLDs]). We used the Cause of Death Ensemble model (CODEm) approach to estimate deaths due to diabetes, incorporating 25 666 location-years of data from vital registration and verbal autopsy reports in separate total (including both type 1 and type 2 diabetes) and type-specific models. Other forms of diabetes, including gestational and monogenic diabetes, were not explicitly modelled. Total and type 1 diabetes prevalence was estimated by use of a Bayesian meta-regression modelling tool, DisMod-MR 2.1, to analyse 1527 location-years of data from the scientific literature, survey microdata, and insurance claims; type 2 diabetes estimates were computed by subtracting type 1 diabetes from total estimates. Mortality and prevalence estimates, along with standard life expectancy and disability weights, were used to calculate YLLs, YLDs, and DALYs. When appropriate, we extrapolated estimates to a hypothetical population with a standardised age structure to allow comparison in populations with different age structures. We used the comparative risk assessment framework to estimate the risk-attributable type 2 diabetes burden for 16 risk factors falling under risk categories including environmental and occupational factors, tobacco use, high alcohol use, high body-mass index (BMI), dietary factors, and low physical activity. Using a regression framework, we forecast type 1 and type 2 diabetes prevalence through 2050 with Socio-demographic Index (SDI) and high BMI as predictors, respectively. FINDINGS: In 2021, there were 529 million (95% uncertainty interval [UI] 500-564) people living with diabetes worldwide, and the global age-standardised total diabetes prevalence was 6·1% (5·8-6·5). At the super-region level, the highest age-standardised rates were observed in north Africa and the Middle East (9·3% [8·7-9·9]) and, at the regional level, in Oceania (12·3% [11·5-13·0]). Nationally, Qatar had the world's highest age-specific prevalence of diabetes, at 76·1% (73·1-79·5) in individuals aged 75-79 years. Total diabetes prevalence-especially among older adults-primarily reflects type 2 diabetes, which in 2021 accounted for 96·0% (95·1-96·8) of diabetes cases and 95·4% (94·9-95·9) of diabetes DALYs worldwide. In 2021, 52·2% (25·5-71·8) of global type 2 diabetes DALYs were attributable to high BMI. The contribution of high BMI to type 2 diabetes DALYs rose by 24·3% (18·5-30·4) worldwide between 1990 and 2021. By 2050, more than 1·31 billion (1·22-1·39) people are projected to have diabetes, with expected age-standardised total diabetes prevalence rates greater than 10% in two super-regions: 16·8% (16·1-17·6) in north Africa and the Middle East and 11·3% (10·8-11·9) in Latin America and Caribbean. By 2050, 89 (43·6%) of 204 countries and territories will have an age-standardised rate greater than 10%. INTERPRETATION: Diabetes remains a substantial public health issue. Type 2 diabetes, which makes up the bulk of diabetes cases, is largely preventable and, in some cases, potentially reversible if identified and managed early in the disease course. However, all evidence indicates that diabetes prevalence is increasing worldwide, primarily due to a rise in obesity caused by multiple factors. Preventing and controlling type 2 diabetes remains an ongoing challenge. It is essential to better understand disparities in risk factor profiles and diabetes burden across populations, to inform strategies to successfully control diabetes risk factors within the context of multiple and complex drivers. FUNDING: Bill & Melinda Gates Foundation.
Alex: [concluding with quiet conviction] Exactly. It maps the trajectory of the epidemic, but the actual reversal of these trends depends on factors—like social and logistical barriers—that this model identifies as the critical, yet unaddressed, challenges.
Alex: [steady, matter-of-fact] By 2050, more than 1.31 billion people are projected to be living with diabetes, with nearly half of that increase driven by demographic shifts alone. That is the central projection from the latest Global Burden of Disease analysis.
Sam: [leaning in, analytical] That is a staggering figure. When you say demographic shifts are driving half the increase, are we talking primarily about aging, or the interaction with obesity?
Alex: [measured, analytical] It is both, but the model isolates them. While population growth and aging expand the raw numbers, rising obesity is the primary engine.
Sam: [thoughtful, probing] To get there, the authors had to navigate a massive data gap. Many national registries don't even distinguish between type 1 and type 2. How did they harmonize that?
Alex: [clear, pedagogical] They used a Bayesian meta-regression framework called DisMod-MR 2.1. Think of it as a jigsaw puzzle where the model uses mortality and incidence data as the edges to force the middle pieces—prevalence—to fit together, even when data is missing.
Sam: [nodding] Right, so they enforce internal consistency via differential equations. But if the input data is noisy, doesn't that propagate the error?
Alex: [deliberate, checking understanding] That is the risk. To mitigate it, they subtracted type 1 estimates from total counts. Since type 1 is more reliably captured in hospital data, this acts as a filter to isolate the type 2 burden. [[RP_SECTION:model-limitations-and-covariates|Model Limitations and Covariates]]
Sam: [skeptical, pushing back] Even with that, the reliance on high body-mass index as a primary covariate seems heavy. Does the model account for the fact that this relationship varies across ethnic or socioeconomic groups?
Alex: [measured, acknowledging the limitation] The model uses a comparative risk assessment framework. It acknowledges that risk factor profiles aren't uniform, but it is constrained by the available global data on those disparities.
Sam: [reflective] So the study provides the granular, age-stratified data a public health official needs to justify screening, but it remains a top-down model. It can't predict how a local policy intervention might break those trends.
Alex: [concluding with quiet conviction] Exactly. It maps the trajectory of the epidemic, but the actual reversal depends on factors—like social and logistical barriers—that this model identifies as the critical, yet unaddressed, challenges.
Sam: [lightly] If you want to see how they accounted for those specific regional variables, check out the supplementary tables in the paper.
Alex: [warmly] Thanks for walking through this with me. [[RP_SECTION:data-quality-and-robustness|Data Quality and Robustness]]
Sam: [leaning in, analytical] We have covered the projections, but I am curious about the data quality. The authors exclude self-reported diabetes. How does that affect robustness?
Alex: [measured, analytical] It is a significant design choice. By filtering self-reported data, they avoid reporting bias from varying diagnostic access. It creates a more stable, albeit conservative, baseline focused on blood-glucose-validated cases.
Sam: [thoughtful, probing] That makes sense. But they also mention many studies use a single glucose test, which might over-code prevalence. Did they adjust for that measurement error?
Alex: [steady, precise] They did not fully correct for it because the error magnitude shifts depending on the underlying blood sugar distribution. They acknowledge this as a limitation, noting it likely leads to an overestimation in certain regions.
Sam: [nodding, processing] So, the model is a high-level, top-down synthesis. It maps the global trajectory well, but it lacks the local resolution to account for specific cohort effects.
Alex: [deliberate, checking understanding] Exactly. It is a macro-level tool. It captures the primary driver—high body-mass index—but cannot yet integrate nuanced, local-level risk factors like socioeconomic status or ethnic profiles. [[RP_SECTION:future-predictive-modeling|Future Predictive Modeling]]
Sam: [reflective] It sounds like the next step is moving from these global forecasts toward dynamic, local early-warning systems. If they integrated real-time electronic health record data, the predictive power would be much higher.
Alex: [concluding with quiet conviction] That is the direction. The current model serves as a vital baseline, but the future lies in closing the gap between these global estimates and the granular data needed for local policy.
Sam: [lightly] If you want to see the specific regional breakdowns or the supplementary tables, you can generate a deep dive of this paper. The paper has the rest either way.
Alex: [warmly] Thanks for listening.